Eflornithine is Safer Than Melarsoprol for the Treatment of Second-Stage Trypanosoma Brucei Gambiense Human African Trypanosomiasis.
AffiliationMédecins Sans Frontières, Geneva University Hospitals, Geneva, Switzerland. firstname.lastname@example.org
MetadataShow full item record
JournalClinical Infectious Diseases
AbstractPatients with second-stage human African trypanosomiasis treated with eflornithine (n = 251) in 2003 in Kiri, southern Sudan, had an adjusted relative risk of death of 0.2 and experienced significantly fewer cutaneous and neurological adverse effects than did patients who were treated with melarsoprol in 2001 and 2002 (n = 708).
- The treatment of human African trypanosomiasis.
- Authors: Pépin J, Milord F
- Issue date: 1994
- Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo.
- Authors: Balasegaram M, Harris S, Checchi F, Ghorashian S, Hamel C, Karunakara U
- Issue date: 2006 Oct
- Gambian trypanosomiasis and synergism between melarsoprol and eflornithine: first case report.
- Authors: Simarro PP, Asumu PN
- Issue date: 1996 May-Jun
- Melarsoprol-free drug combinations for second-stage Gambian sleeping sickness: the way to go.
- Authors: Chappuis F
- Issue date: 2007 Dec 1
- [A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo].
- Authors: Eozenou P, Jannin J, Ngampo S, Carme B, Tell GP, Schechter PJ
- Issue date: 1989 Apr-Jun